SIRT3 and metabolic dysfunction-associated steatotic liver disease: Higher NAD+ levels can enhance the activity of sirtuin 1 (SIRT1) and sirtuin 3 (SIRT3), which have been reported to protect mice from fatty liver diseases such as NAFLD [103,104].